Acerus Pharmaceuticals Corporation  

(Public, CVE:JV.P)   Watch this stock  
Find more results for Gregory P. Hawkins�
0.120
Feb 4 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.01 - 0.21
Open     -
Vol / Avg. 0.00/19,467.00
Mkt cap 1.20M
P/E     -
Div/yield     -
EPS -0.10
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 56.86% -53.39%
Operating margin 78.13% -65.37%
EBITD margin - 23.72%
Return on average assets 80.58% -17.12%
Return on average equity 1241.59% -129.00%
Employees 16 -
CDP Score - -

Address

2488 Dunwin Dr
MISSISSAUGA, ON L5L 1J9
Canada
+1-416-6790771 (Phone)

Website links

Description

Acerus Pharmaceuticals Corporation, formerly Trimel Pharmaceuticals Corporation, is a Canada-based pharmaceutical company. The Company is engaged in the development, manufacture, marketing and distribution of products with a focus on men's health, including urology, and women's health, including hormone replacement therapy and female sexual dysfunction. The Company markets Estrace in Canada, which is an oral, plant-derived 17-beta estradiol therapy for the relief of symptoms of menopause. The Company offers Natesto, which is the testosterone nasal gel in the United States for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone (hypogonadism). The Company offers TEFINA, which is a low-dose nasal testosterone gel treatment in development for female sexual dysfunction. The Company focuses on TriVair Deposition/Dispersion System, which is a unit dose dry powder inhaler and nasal dispersion system.

Officers and directors

Ian O. Ihnatowycz Independent Chairman of the Board
Age: 62
Tom Rossi President, Chief Executive Officer, Director
Matthew Hawkins Vice President - Legal Affairs, Corporate Secretary
Nathan Bryson Vice President - Scientific Affairs
Rolf K. Reininghaus Executive Director, Director
Stephen Robert Gregory Lead Independent Director
Norma Beauchamp Director
Borys Chabursky Director
Luc Mainville Director
Age: 52
Josef Vejvoda Director
Age: 50